Earningshttps://www.newsfilecorp.com/release/104276/Quinsam-Announces-Q32021-Results Quinsam Announces Q3/2021 Results Toronto, Ontario--(Newsfile Corp. - November 18, 2021) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") wishes to announce its Q3/2021 results, with a net loss of $0.7 million ($0.01 per share basic, $0.01 fully diluted) versus net income of $0.8 million ($0.01 per share basic, $0.01 fully diluted) in Q3/2020. Investors can access the Company's full financial statements on sedar.com. "At September 30, 2021, we had net assets of $0.341 per share, still up materially from our December 31, 2020 level of $0.317 per share," said Roger Dent, CEO of Quinsam. "Our NAV was down marginally from $0.345 at the end of Q2/2021, with the impact of our Q3/2021 loss being offset to a significant degree by the favourable impact of our normal course issuer bid repurchases of shares at a discount to NAV. We also paid a dividend of $0.00125 per share. Our NAV decline in the quarter was only about 1%." Q3/2021 Results & Update After a strong performance in Q1/2021, the overall tone in the small cap market moderated in Q2/2021. In Q3/2021, small cap markets remained subdued with significant volatility in many parts of the market. The TSX Venture Composite index declined from 960.69 on June 30, 2021 to 858.87 on September 30, 2021, a decline of 10.6%. "We had hoped for a better result in Q3/2021," said Roger Dent, CEO of Quinsam Capital. "While our NAV did not grow in Q3/2021, as has been the case for some time, we have continued to move into newer investments where we see better appreciation potential." Quinsam had two issuers with material liquidity events early in Q3/2021: Agriforce Growing Systems and Hempsana. Unfortunately, in the context of the difficult small cap market, both of these companies saw share price declines following their listings on no reported negative developments. Accordingly, these events did not contribute to NAV growth. In Q3/2021, we also received the full repayment of our loan to Herbiculture Inc., a Maryland dispensary operation. We retain an option to acquire 30% of the dispensary. In October 2021, our investee PMML went public under the name Rivalry Corp. This has been a very successful investment for us. In 2016, we purchased $50,000 of units at the equivalent of $0.225 (including a full warrant coverage at C$0.225) versus the current share price of about $3 per share, similar to our Q3/2021 carrying value. Quinsam expects liquidity events in the coming months by a number of issuers. While Q3/2021 liquidity events did not contribute to NAV, we are hopeful that upcoming liquidity events will have a more favourable impact. Some issuers where we expect liquidity events in the coming months include Liquid Meta (crypto currency liquidity provider), INX (SEC-cleared crypto currency trading platform), Pluribus (software roll up), Strategic Minerals Europe (tin), Forrest Innovations (mosquito control technology) and Givex (payment processing technology), As we move into 2022, we are also looking forward to listings by Above Food (plant based food), Music Royalties, Peninsula Capital (high yield US residential real estate), Gefion (innovative transdermal drug delivery technology), Chargerquest (electric car charging stations), Green Stripe (cannabis), Budbank (cannabis), Canada Energy Partners (Gabon oil & gas), Pfane (circuit board recycling) and other investee companies. We have acquired positions in recent months in Givex, Strategic Minerals Europe, Roo Gold, Zodiac Gold, Pfane, ChargerQuest and Forrest Innovations. Issuer Bid In Q3/2021, Quinsam acquired 2,609,500 shares pursuant to its issuer bid to acquire up to 5,174,605 shares that commenced on August 31, 2021 and will terminate on August 30, 2022. As a result of the purchases in Q3/2021, to date the Company has acquired 2,609,500 shares pursuant to this issuer bid. Quinsam has now repurchased and cancelled 19.6 million shares since 2018 pursuant to its issuer bids, resulting in significant NAV accretion for remaining shareholders.